Zacks Investment Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-170
Closed -$64K 532
2020
Q4
$64K Hold
170
﹤0.01% 511
2020
Q3
$52K Hold
170
﹤0.01% 493
2020
Q2
$64K Hold
170
﹤0.01% 494
2020
Q1
$39K Sell
170
-599
-78% -$137K ﹤0.01% 484
2019
Q4
$407K Buy
+769
New +$407K 0.01% 465